Related Experiment Videos
[Effect of captopril in chronic aortic insufficiency]
Zeitschrift Fur Kardiologie
|May 1, 1986
Summary
Captopril acutely improved ejection fraction in chronic aortic regurgitation patients. However, long-term captopril therapy did not significantly alter cardiac function despite lowering blood pressure and increasing plasma renin activity.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Context:
- Chronic aortic regurgitation (AR) presents significant hemodynamic challenges.
- Angiotensin-converting enzyme inhibitors like captopril are used to manage cardiovascular conditions.
- Understanding captopril's effects in AR is crucial for optimizing treatment strategies.
Purpose:
- To investigate the acute and chronic hormonal and hemodynamic effects of captopril in patients with chronic aortic regurgitation.
- To assess changes in left ventricular ejection fraction (EF), end-diastolic volume (EDV), regurgitant blood volume (RBV), and plasma renin activity (PRA).
Summary:
- Acute captopril administration (12.5-25 mg) significantly increased EF (49% to 55%) and PRA in 16 AR patients.
- Chronic therapy (4-8 weeks) moderately reduced blood pressure but did not significantly improve EF, EDV, or RBV.
- Long-term treatment led to a substantial increase in PRA (6.3 ng/ml/h).
Impact:
- Captopril demonstrates acute beneficial effects on left ventricular function in chronic AR.
- The lack of sustained improvement in cardiac function with chronic therapy suggests limitations in this patient group.
- The persistent increase in PRA highlights the drug's potent effects on the renin-angiotensin system.